By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


IntelGenx Corp. 

6425 Abrams Ville Street

Laurent  Quebec  H4S 1X9  Canada
Phone: 514-331-7440 Fax: 514-331-0436



Company News
IntelGenx Corp. Founder Returns As President And CEO 10/2/2014 6:40:58 AM
RedHill Biopharma Ltd. (RDHL) And IntelGenx Corp. Submit European Marketing Authorization Application For Migraine Drug RIZAPORT® (Formerly RHB-103) 10/1/2014 9:12:10 AM
IntelGenx Corp. To Present At Singular Research 9th Annual Best Of The Uncovereds Conference 9/17/2014 10:09:41 AM
IntelGenx Corp. To Present At The Rodman & Renshaw Global Investment Conference 8/21/2014 8:49:49 AM
IntelGenx Corp. Reports Q2, 2014 Results And Provides Corporate Development Update 8/7/2014 8:59:18 AM
IntelGenx Corp. To Host Management Call 7/21/2014 1:42:40 PM
IntelGenx Corp. Announces Equity Analyst Coverage By H.C. Wainwright 7/1/2014 8:46:30 AM
RedHill Biopharma Ltd. (RDHL) And IntelGenx Corp. Report Positive RHB-103 Bioavailability Study Results In Support Of Planned European Marketing Application In Q3/2014 5/21/2014 6:57:13 AM
IntelGenx Corp. Announces Government Of Canada Funding For CNS Versafilm™ Project 4/30/2014 10:00:04 AM
IntelGenx Corp. And RedHill Biopharma Ltd. (RDHL) Announce Commencement Of A Bioavailability Study With Anti-Migraine Versafilm™ Product To Support European Marketing Application Planned For Q3/2014 4/28/2014 9:10:31 AM